Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition

Elena Arystarkhova, Ihtsham U. Haq, Timothy Luebbert, Fanny Mochel, Rachel Saunders-Pullman, Susan B. Bressman, Polina Feschenko, Cynthia Salazar, Jared F. Cook, Scott Demarest, Allison Brashear, Laurie J. Ozelius, Kathleen J. Sweadner

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Dominant mutations of ATP1A3, a neuronal Na,K-ATPase α subunit isoform, cause neurological disorders with an exceptionally wide range of severity. Several new mutations and their phenotypes are reported here (p.Asp366His, p.Asp742Tyr, p.Asp743His, p.Leu924Pro, and a VUS, p.Arg463Cys). Mutations associated with mild or severe phenotypes [rapid-onset dystonia-parkinsonism (RDP), alternating hemiplegia of childhood (AHC), or early infantile epileptic encephalopathy (EIEE)] were expressed in HEK-293 cells. Paradoxically, the severity of human symptoms did not correlate with whether there was enough residual activity to support cell survival. We hypothesized that distinct cellular consequences may result not only from pump inactivation but also from protein misfolding. Biosynthesis was investigated in four tetracycline-inducible isogenic cell lines representing different human phenotypes. Two cell biological complications were found. First, there was impaired trafficking of αβ complex to Golgi apparatus and plasma membrane, as well as changes in cell morphology, for two mutations that produced microcephaly or regions of brain atrophy in patients. Second, there was competition between exogenous mutant ATP1A3 (α3) and endogenous ATP1A1 (α1) so that their sum was constant. This predicts that in patients, the ratio of normal to mutant ATP1A3 proteins will vary when misfolding occurs. At the two extremes, the results suggest that a heterozygous mutation that only impairs Na,K-ATPase activity will produce relatively mild disease, while one that activates the unfolded protein response could produce severe disease and may result in death of neurons independently of ion pump inactivation.

Original languageEnglish (US)
Article number104577
JournalNeurobiology of Disease
Volume132
DOIs
StatePublished - Dec 2019
Externally publishedYes

Keywords

  • Ataxia
  • Cytopathology
  • Dystonia
  • Epilepsy
  • Mutation validation
  • Neurodegeneration
  • Phenotype-genotype relationship

ASJC Scopus subject areas

  • Neurology

Fingerprint Dive into the research topics of 'Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition'. Together they form a unique fingerprint.

  • Cite this

    Arystarkhova, E., Haq, I. U., Luebbert, T., Mochel, F., Saunders-Pullman, R., Bressman, S. B., Feschenko, P., Salazar, C., Cook, J. F., Demarest, S., Brashear, A., Ozelius, L. J., & Sweadner, K. J. (2019). Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition. Neurobiology of Disease, 132, [104577]. https://doi.org/10.1016/j.nbd.2019.104577